Tarceva was supposed to be a blockbuster drug, but following approval, Genentech and OSI Pharmaceuticals, the sponsoring companies, sold off. Analysts see some problems with the drug, but we explain the realities they are missing.
Tarceva was supposed to be a blockbuster drug, but following approval, Genentech and OSI Pharmaceuticals, the sponsoring companies, sold off. Analysts see some problems with the drug, but we explain the realities they are missing.